Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and perioperative immune function in lung cancer surgery
ChiCTR-IPR-15006546Phase 4Not yet recruiting
- Sponsor
- Shenzhen People's Hospital
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in bronchial carcinoma (4 arms), sponsored by Shenzhen People's Hospital. Primary endpoints: Extubation time, Blood pressure and 8 more. Planned start Jul 2015; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR-IPR-15006546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006546.